Pharmaceutical Research & Development | AbbVie
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
Patient Assistance | AbbVie
AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients.
AbbVie - Wikipedia
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74, [2] and rank 89 on the 2024 list. [3]
AbbVie Inc. (ABBV) Stock Price, News, Quote & History - Yahoo Finance
Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Products | AbbVie
AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
AbbVie - LinkedIn
AbbVie | 1,496,713 followers on LinkedIn. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our...
AbbVie and Simcere Zaiming Announce Partnership to Develop a …
6 days ago · AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. AbbVie strives to have a ...
About AbbVie - Our Company | AbbVie
We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.
Our Company - AbbVie
At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. See how we’re improving health care on a global basis.
AbbVie CEO says psychiatric drug space challenging, more …
4 days ago · AbbVie plans to "commit less capital" towards experimental medicines for psychiatric disease, CEO Robert Michael said at an industry conference on Wednesday, months after its experimental ...